• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU404015J
Device Problem Unintended Movement (3026)
Patient Problem Aneurysm (1708)
Event Date 01/11/2019
Event Type  Injury  
Manufacturer Narrative
According to the conformable gore® tag® thoracic endoprosthesis instructions for use (ifu) states that complications associated with the use of the gore® tag® thoracic endoprosthesis may include but are not limited to improper component placement, branch vessel occlusion or obstruction, dissection, perforation, or rupture of the aortic vessel & surrounding vasculature, and neurologic damage, local or systemic (e.G., stroke, paraplegia, paraparesis).
 
Event Description
On (b)(6) 2019, this patient underwent endovascular procedure to treat a thoracic aortic aneurysm using conformable gore® tag® thoracic endoprostheses.It was reported a left subclavian - left common carotid artery bypass was performed, and the device was positioned for deployment at the origin of the left common carotid artery.After deployment of the device, it was reported the device appeared to cover (amount unknown) the left common carotid artery.An additional stent graft was reportedly implanted at the origin of the left common carotid artery and the patient tolerated the procedure.
 
Manufacturer Narrative
Code 213 - a review of the manufacturing paperwork verified this lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8321902
MDR Text Key135568202
Report Number2017233-2019-00073
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/20/2021
Device Catalogue NumberTGU404015J
Device Lot Number18608153
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/08/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-